CA1313835C - Extraction of carotenoproteins from crustacean wastes - Google Patents
Extraction of carotenoproteins from crustacean wastesInfo
- Publication number
- CA1313835C CA1313835C CA000487392A CA487392A CA1313835C CA 1313835 C CA1313835 C CA 1313835C CA 000487392 A CA000487392 A CA 000487392A CA 487392 A CA487392 A CA 487392A CA 1313835 C CA1313835 C CA 1313835C
- Authority
- CA
- Canada
- Prior art keywords
- carotenoproteins
- trypsin
- carotenoprotein
- antioxidant
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002699 waste material Substances 0.000 title claims abstract description 22
- 238000000605 extraction Methods 0.000 title claims abstract description 20
- 241000238424 Crustacea Species 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 31
- 102000004142 Trypsin Human genes 0.000 claims abstract description 22
- 108090000631 Trypsin Proteins 0.000 claims abstract description 22
- 239000012588 trypsin Substances 0.000 claims abstract description 22
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- 108091005804 Peptidases Proteins 0.000 claims abstract description 13
- 239000004365 Protease Substances 0.000 claims abstract description 11
- 230000001580 bacterial effect Effects 0.000 claims abstract description 11
- 229920002101 Chitin Polymers 0.000 claims abstract description 10
- 239000006052 feed supplement Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 241001465754 Metazoa Species 0.000 claims abstract description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract 3
- 239000007864 aqueous solution Substances 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 17
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 14
- 235000013793 astaxanthin Nutrition 0.000 claims description 14
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 14
- 229940022405 astaxanthin Drugs 0.000 claims description 14
- 239000001168 astaxanthin Substances 0.000 claims description 14
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 230000003078 antioxidant effect Effects 0.000 claims description 10
- 235000006708 antioxidants Nutrition 0.000 claims description 10
- 239000002738 chelating agent Substances 0.000 claims description 10
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 241000283690 Bos taurus Species 0.000 claims description 8
- 108010039627 Aprotinin Proteins 0.000 claims description 6
- HDLNSTQYXPTXMC-UHFFFAOYSA-N Astaxanthin-diacetat Natural products O=C1C(OC(=O)C)CC(C)(C)C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=2C(CC(C(=O)C=2C)OC(C)=O)(C)C)=C1C HDLNSTQYXPTXMC-UHFFFAOYSA-N 0.000 claims description 6
- FMKGDHLSXFDSOU-BDPUVYQTSA-N Dienon-Astacin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(=CC1(C)C)O)C=CC=C(/C)C=CC2=C(C)C(=O)C(=CC2(C)C)O FMKGDHLSXFDSOU-BDPUVYQTSA-N 0.000 claims description 6
- RASZIXQTZOARSV-QISQUURKSA-N astacene Chemical compound CC=1C(=O)C(=O)CC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)C(=O)CC1(C)C RASZIXQTZOARSV-QISQUURKSA-N 0.000 claims description 6
- 210000000496 pancreas Anatomy 0.000 claims description 6
- 229940108519 trasylol Drugs 0.000 claims description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- 229960001484 edetic acid Drugs 0.000 claims description 5
- 239000008363 phosphate buffer Substances 0.000 claims description 4
- 238000000265 homogenisation Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000003086 colorant Substances 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 23
- 102000004169 proteins and genes Human genes 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 23
- 235000021466 carotenoid Nutrition 0.000 description 17
- 150000001747 carotenoids Chemical class 0.000 description 17
- 241000238557 Decapoda Species 0.000 description 16
- 229940088598 enzyme Drugs 0.000 description 11
- 102000035195 Peptidases Human genes 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- 238000011084 recovery Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000277275 Oncorhynchus mykiss Species 0.000 description 4
- 241000277331 Salmonidae Species 0.000 description 4
- 230000000050 nutritive effect Effects 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000143060 Americamysis bahia Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000037230 mobility Effects 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000007065 protein hydrolysis Effects 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 241001132374 Asta Species 0.000 description 1
- 241000239250 Copepoda Species 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- -1 Hydroxylysine o Chemical class 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101800001646 Protein n Proteins 0.000 description 1
- 101150052091 Sarnp gene Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- BTKOPDXMVKYSNL-UHFFFAOYSA-N [Na].[Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O Chemical compound [Na].[Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O BTKOPDXMVKYSNL-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 235000020930 dietary requirements Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Animal Husbandry (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
A process is provided for the extraction of carotenoproteins from crustacean wastes. The process comprises the steps of (a) homogenizing the crustacean waste in water to form a homogenizate; (b) treating the homogenizate with at least 0.1%
w/w based on the crustacean waste of a proteolyte enzyme selected from the group consisting of animal-derived trypsin and a bacterial protease, at a temperature of 0°C to 50°C for from 1 to 24 hours; and (c) separating an aqueous solution of carotenoproteins therefrom, the carotenoproteins being substantially free of chitin and ash. Such carotenoproteins may be used as a tissue colorant feed supplement.
A process is provided for the extraction of carotenoproteins from crustacean wastes. The process comprises the steps of (a) homogenizing the crustacean waste in water to form a homogenizate; (b) treating the homogenizate with at least 0.1%
w/w based on the crustacean waste of a proteolyte enzyme selected from the group consisting of animal-derived trypsin and a bacterial protease, at a temperature of 0°C to 50°C for from 1 to 24 hours; and (c) separating an aqueous solution of carotenoproteins therefrom, the carotenoproteins being substantially free of chitin and ash. Such carotenoproteins may be used as a tissue colorant feed supplement.
Description
1~ 131383~
This invention relates to the extraction o~ carotenoproteins from crustacean waste products. Such carotenoproteins may be used as a source of tissue colorant feed supplement.
Carotenoid pigments are useful in rearing salmon and trout in hatcheries or fish farms. Such fish, when reared on conventional diets lack the skin and flesh coloration normally associated in the consumer mind with these fish species. The pigments found in the shells and tissues of crustaceans have been found to impart this colour to salmon and trout. Lyle K.
Anderson in Canadian Patent 1,044,505 issued on 19 December 1978 details an oil~based extraction method for the preparation of a carotenoid pigment from crustacean shell waste. However, problems associated with such products include a decreased stability to oxidation and reduced nutritive value.
It is an object of a broad aspect of this invention to mitigate problems of decreased stability and reduced nutritive value associated with prior art products, to provide a novel extraction process and to yield a product of an improved stability and nutritive value.
By a broad aspect of this invention, a process is provided for the extraction of carotenoproteins from crustacean waste comprising the steps of: (a) homogenizing the crustacean waste in water to form a homogenizate; (b) treating the homogenizate with at least 0.1% w/w based on the crustacean waste of a proteolyte enzyme selected from the groups consisting of animal-derived trypsin and a bacterial protease, at a temperature of ooc to 50C for from l to 24 hours; and (c) separating an aqueous .~31383~
This invention relates to the extraction o~ carotenoproteins from crustacean waste products. Such carotenoproteins may be used as a source of tissue colorant feed supplement.
Carotenoid pigments are useful in rearing salmon and trout in hatcheries or fish farms. Such fish, when reared on conventional diets lack the skin and flesh coloration normally associated in the consumer mind with these fish species. The pigments found in the shells and tissues of crustaceans have been found to impart this colour to salmon and trout. Lyle K.
Anderson in Canadian Patent 1,044,505 issued on 19 December 1978 details an oil~based extraction method for the preparation of a carotenoid pigment from crustacean shell waste. However, problems associated with such products include a decreased stability to oxidation and reduced nutritive value.
It is an object of a broad aspect of this invention to mitigate problems of decreased stability and reduced nutritive value associated with prior art products, to provide a novel extraction process and to yield a product of an improved stability and nutritive value.
By a broad aspect of this invention, a process is provided for the extraction of carotenoproteins from crustacean waste comprising the steps of: (a) homogenizing the crustacean waste in water to form a homogenizate; (b) treating the homogenizate with at least 0.1% w/w based on the crustacean waste of a proteolyte enzyme selected from the groups consisting of animal-derived trypsin and a bacterial protease, at a temperature of ooc to 50C for from l to 24 hours; and (c) separating an aqueous .~31383~
- 2 -solution of carotenoproteins therefrom, the carotenoproteins being substantially free of chitin and ash.
In one variant thereof, the homogenization step is carried out in the presence of a chelating agent; ancl preferably wherein the chelating agent is ethylene diamine tetraacetic acid.
In other variants, the trypsin may he ~ovine pancreas trypsin or porcine pancreas trypsin; or the bacterial protease may be ENZECO AP_1TM or BIOCON.~M.
In still another variant, the treating step is carried out in the presence of a phosphate buffer.
In a still further variant, the process includes the step of adding an antioxidant and a protease inhibitor to the treated homogenizate bef~re the separation step; and preferably wherein the antioxidant is BHT and wherein the protease inhibitor is trasylol.
By another aspect of this invention, an extract composition is provided comprising a carotenoprotein substantially free of chitin and ash and containing major amounts of free astaxanthin, astaxanthin ester and purer amounts of astacene.
In one variant thereof, the extract composition is provided in combination with a protease inhibitor and an antioxidant; and preferably wherein the protease inhibitor is trasylol and wherein the antioxidant is BHT.
By still another aspect of this invention a feed supplement is provided containing such extract composition.
,'``~ :' ~3~383~
- 2a -In the accompanying drawings, ~igure 1 shows a schematic outline of an embodiment of the invention; and Figure 2 compares the amino acid composition of carotenoprotein obtained by the process of the invention, the dietary requirements of rainbow trout and the amino acid proportions provided in a diet composed of 40% carotenoprotein with no other protein source.
Example 1 - Extraction of carotenoprotein with EDTA and proteolytic enzymes.
Extraction of carotenoprotein was carried out in the presence of 0.5M trisodium ethylenediamine tetra acetic acid (EDTA). Proteolytic enzymes were then used to facilitate extraction of carotenoprotein. The method involved homogenizing 25 g of either cooked or uncooked sample with 75 mL of col (-4C) 0.5M trisodium EDTA (pH 7.7~ using a POLYTRONTM at setting 6 for 2 min. To the homogenate was added 25 mg of one of BT = pure bovine pancreas trypsin, PT = technical grade porcine pancreas trypsin, and EP = ENZECO AP_1TM protease, or control = no enzyme added. The samples were shaken at 200 r.p.m. on a laboratory rotator at 4C for various time intervals from 1 to 2~ hrs. The homogenat~s were then filtered through several layers of cheesecloth and the filtrate pH was adjusted to 7.5 with 2M HCl and made to 45% saturation with solid ammonium sulfate. The carotenoprotein was recovered by centrifugation was suspended in 20 mL of 5mM phosphate buffer (pH 7O0~ 4C) and dialysed against 13~3~
- 2b -
In one variant thereof, the homogenization step is carried out in the presence of a chelating agent; ancl preferably wherein the chelating agent is ethylene diamine tetraacetic acid.
In other variants, the trypsin may he ~ovine pancreas trypsin or porcine pancreas trypsin; or the bacterial protease may be ENZECO AP_1TM or BIOCON.~M.
In still another variant, the treating step is carried out in the presence of a phosphate buffer.
In a still further variant, the process includes the step of adding an antioxidant and a protease inhibitor to the treated homogenizate bef~re the separation step; and preferably wherein the antioxidant is BHT and wherein the protease inhibitor is trasylol.
By another aspect of this invention, an extract composition is provided comprising a carotenoprotein substantially free of chitin and ash and containing major amounts of free astaxanthin, astaxanthin ester and purer amounts of astacene.
In one variant thereof, the extract composition is provided in combination with a protease inhibitor and an antioxidant; and preferably wherein the protease inhibitor is trasylol and wherein the antioxidant is BHT.
By still another aspect of this invention a feed supplement is provided containing such extract composition.
,'``~ :' ~3~383~
- 2a -In the accompanying drawings, ~igure 1 shows a schematic outline of an embodiment of the invention; and Figure 2 compares the amino acid composition of carotenoprotein obtained by the process of the invention, the dietary requirements of rainbow trout and the amino acid proportions provided in a diet composed of 40% carotenoprotein with no other protein source.
Example 1 - Extraction of carotenoprotein with EDTA and proteolytic enzymes.
Extraction of carotenoprotein was carried out in the presence of 0.5M trisodium ethylenediamine tetra acetic acid (EDTA). Proteolytic enzymes were then used to facilitate extraction of carotenoprotein. The method involved homogenizing 25 g of either cooked or uncooked sample with 75 mL of col (-4C) 0.5M trisodium EDTA (pH 7.7~ using a POLYTRONTM at setting 6 for 2 min. To the homogenate was added 25 mg of one of BT = pure bovine pancreas trypsin, PT = technical grade porcine pancreas trypsin, and EP = ENZECO AP_1TM protease, or control = no enzyme added. The samples were shaken at 200 r.p.m. on a laboratory rotator at 4C for various time intervals from 1 to 2~ hrs. The homogenat~s were then filtered through several layers of cheesecloth and the filtrate pH was adjusted to 7.5 with 2M HCl and made to 45% saturation with solid ammonium sulfate. The carotenoprotein was recovered by centrifugation was suspended in 20 mL of 5mM phosphate buffer (pH 7O0~ 4C) and dialysed against 13~3~
- 2b -
3 changes of 6L of the same buffer at ~C overnight. The dialysed carotenoprotein was lyophilized prior to chemical analyses. Thin layer chromatography of carotenoid extracts.
The carotenoid extracts were chromatographed on silica gel G thin layer plates using the method of J. P. Meyers and D. Bligh in J. Agric. Food Chem 29, ~1981). The solvent system used for the chromatography was benzene: petroelum ether:acetone (10:3:2).
The relative mobilities of free astaxanthin, astaxanthin ester and asta~ene were compared to those of components in extracts from shrimp offal and -~.
--3~~ ' ~3~3~3~
f`rom the caro,ter)oproteln Lsolate.
Proxlmate compo.siti.or) The proxllllate compositLorls oP uncooked shrimp processing wa3te, carotenoprotein and residue after freeze dryine are shown in Table 1.
'rhe chitin contained in these fractions was separately deterrnined and found to be 13.6~, 0% and 27.3% (dwb), respectivel.y. These data show that shrirnp carotenoprotein is enriched in protein by appro~xima.t.el,y,,.~O,%
and depleted of chitLn and..of.~h. About 80% of the protein and carotenoid wlth t~le shrimp processlng waste was recovered in the caroterloprotein fraction that was prepared with bovlne trypsln by the process outlined in Fi.gure 1. The influence of extraction time on the recovery of protein in the carotenoprotein fraction was studied.
Addition of' bovine trypsin, commercial grade porcine trypsLn or food grade Enzeco bacterial protease to the homogenate were all e~fective ln improving the recovery of protein Ln the carotenoprotein fract:Lon. The extraction of protein without added enzyme was somewhat faster with uncooked offal than with cooked offal. Part of the readily solubilized protein from uncooked offal may represent water soluble proteins normally lost durinx cookLng. It is also possible that endo~enous enzymes al.so contribute to the solubLlization of protein from uncooked sample.
Salmonids have a demanding requirement for dietary protein and excess chitin can be undesirable in aquaculture rations. On the basis of the above considerati.ons, the fractionation process outlined in Figure 1 would appear to improve the feed value of shrimp waste.
3o ~ 3~
,, TAl3L,E 1-: I'roxLnlate1 composlt~on of' f'reeze-dried shriMp waste, shrilnp carotel1oprotein and extracted residue1, ___ __ ___ _ _ ___ _ _____ ___. __ COMPONENTSHRIMP WASTE SHRIMP RESIDUE
Carotenoprotein _.____ __ ___ Crude protein2 43.13 ND ND
Protein 331.7 58.4 12.7 Crude Fat25.2 26.9 12.0 10 Ash 26.0 7.5 31.2 Moisture 4.4 3.5 6.3 Carbohydrate4 14.2 3.7 37.o ____ _ __ _ _ _ .
Total Astaxanthinl 11.9 116.0 ND
(mg%) Data are average values of duplicate determination; ND = not determined.
1 Data for uncooked shrimp waste processed as shown in Fig. 1.
20 2 N content x 7.25, not corrected for chitin 3 Protein determined by the Biuret method
The carotenoid extracts were chromatographed on silica gel G thin layer plates using the method of J. P. Meyers and D. Bligh in J. Agric. Food Chem 29, ~1981). The solvent system used for the chromatography was benzene: petroelum ether:acetone (10:3:2).
The relative mobilities of free astaxanthin, astaxanthin ester and asta~ene were compared to those of components in extracts from shrimp offal and -~.
--3~~ ' ~3~3~3~
f`rom the caro,ter)oproteln Lsolate.
Proxlmate compo.siti.or) The proxllllate compositLorls oP uncooked shrimp processing wa3te, carotenoprotein and residue after freeze dryine are shown in Table 1.
'rhe chitin contained in these fractions was separately deterrnined and found to be 13.6~, 0% and 27.3% (dwb), respectivel.y. These data show that shrirnp carotenoprotein is enriched in protein by appro~xima.t.el,y,,.~O,%
and depleted of chitLn and..of.~h. About 80% of the protein and carotenoid wlth t~le shrimp processlng waste was recovered in the caroterloprotein fraction that was prepared with bovlne trypsln by the process outlined in Fi.gure 1. The influence of extraction time on the recovery of protein in the carotenoprotein fraction was studied.
Addition of' bovine trypsin, commercial grade porcine trypsLn or food grade Enzeco bacterial protease to the homogenate were all e~fective ln improving the recovery of protein Ln the carotenoprotein fract:Lon. The extraction of protein without added enzyme was somewhat faster with uncooked offal than with cooked offal. Part of the readily solubilized protein from uncooked offal may represent water soluble proteins normally lost durinx cookLng. It is also possible that endo~enous enzymes al.so contribute to the solubLlization of protein from uncooked sample.
Salmonids have a demanding requirement for dietary protein and excess chitin can be undesirable in aquaculture rations. On the basis of the above considerati.ons, the fractionation process outlined in Figure 1 would appear to improve the feed value of shrimp waste.
3o ~ 3~
,, TAl3L,E 1-: I'roxLnlate1 composlt~on of' f'reeze-dried shriMp waste, shrilnp carotel1oprotein and extracted residue1, ___ __ ___ _ _ ___ _ _____ ___. __ COMPONENTSHRIMP WASTE SHRIMP RESIDUE
Carotenoprotein _.____ __ ___ Crude protein2 43.13 ND ND
Protein 331.7 58.4 12.7 Crude Fat25.2 26.9 12.0 10 Ash 26.0 7.5 31.2 Moisture 4.4 3.5 6.3 Carbohydrate4 14.2 3.7 37.o ____ _ __ _ _ _ .
Total Astaxanthinl 11.9 116.0 ND
(mg%) Data are average values of duplicate determination; ND = not determined.
1 Data for uncooked shrimp waste processed as shown in Fig. 1.
20 2 N content x 7.25, not corrected for chitin 3 Protein determined by the Biuret method
4 Carbohydrate calculated by difference and represents chitin and other minor solids.
----- ... - .. ... _. ..
~5~ 13~38'~
Amino acid cornpo~,itlon of carotenoproteln The amino aci(l data presented in Table 2 indleate that carotenoprotein isolate(l by t~le procedure outllned in Fi8ure l, is particularly rlcn in elutamic acid and aspartlc acid, similar to earlier findings on carotenoprotein derived from a copepod. The amino aeid composition of the produet extracted with bovine trypsin is only marginally different from that of the untreated product. On a rnole percent basis, the carotenoprotein obtained by extraction with bovine trypsin is a somewhat better source of essential amino acids isoleucine, leucine, phenylalanine, threonine, tryptophan and tyrosine than the earotenoprotein obtained ln the absenee of added enzymes; whieh in turn is a somewhat better source of arglnine, methionine and lysine. The valine and histidine levels of the carotenoprotein extraeted wlth bovine trypsin were slmilar to those in the product obtained in the absence of added en~yme. Figure 2 compares the levels of essential amino acids from rainbow trout nutrition with the carotenoprotein isolate prepared with bovLne trypsin. The carotenoprotein isolate contains an exeess of essential amino aeids required for rainbow trout. As ean be seen from Figure 2 a ration eontaining 40~ earotenoprotein, and no other protein source, would be more than adequate in all essential arnino aeids with exception of cystine. The second limiting amino acids are methionine, arginine and lysine. A ration of l~o~ carotenoprotein would also eontain more that 50 me% of earotenoids, an amount suffieient to pigment rainbow trout.
-6- 13~3~
. I'ABL.E 2: Amino Acid Levels in Carotenoprotein Amino AcidControlcontrolBT-treatedBT-treated ,~ proteinmole ,~6% proteinmole ',~
Alanine 5.17 7.97 5.20 7.75 Arginine 6.12 4.83 4.46 3.39 Aspartate11.14 11,,49 10.80 10.77 Cysteic acid 0.22 0.17 0.77 0.60 Cystine O.IJ0 0,46 0.58 0.65 Clutamate12.06 11,,26 11.78 l0.63 Glycine 4.46 8,18 ll.77 8.43 Histidine3.02 2.67 2.95 2.52 Hydroxylysine o.o9 o.o7 0.22 0,17 Hydroxyproline 0.09 0.07 0.18 0.20 Isoleucine4.68 4.89 5-14 5.18 Leucine 7.05 7.37 7.97 8.06 Lysine 6.71 6.28 5.66 5.14 Methionine2.62 2.40 1.88 1.68 Phenylalanine 1l.83 4.01 5.66 4,54 Proline 4.25 5.07 4.3ll 5.00 Serine 4.68 6.09 5.54 6.97 Taurine 0.09 0.12 0.12 0.14 Threonine5.38 6.21 6.25 6.95 Tryptophan1.17 0.78 2.40 1.56 Tyrosine 4.3ll 3.29 4.86 3.56 Valine 5.42 6.33 5.42 6.11 . . . ~
Data are averaee values of duplicate determinations.
~7 131383~
Recovery of c~IrotenoLcI plgments Approxl~nately ~0% of the carotenoids with shrimp processing wastes (Il - 12 mg% fwb) were recovered in the carotenoproteLn fractlon when bovine trypsin was included in the extraction medium. The use of trypsin increased the recovery of pigment at all extractlon tlmes employed. The bacterial protease was le~s effective than trypsin(s) in recovering carotenoprotein despite its effectiveness in solubilizing protein. The specificity of this enzyme is broader than that of trypsin and its action may result in excessive hydrolysis of protein associated with the carotenoprotein complex and thereby lead to insolubllity ln the aqueous extraction solution or to instability due to dlsruptlon of the protective environment provided by association with protein. Further study with different enzymes, as well as varying concentrations of en~ymes will be necessary to elucidate the reason for the dLfferences in yield obtained wlth trypsin and bacterial protease.
The maximum absorbance of the carotenoid fraction from shrimp waste and from carotenoprotein isolate was ~I75 nm in petroleum ether.
These results are consistent with other reports for total astaxanthin.
Thin layer chromatography of the carotenoLd fraction from raw or cooked shrimp offal separated three distinct orange-red components. The separated components of raw and cooked shrimp waste had Rf's 0.29 -0.32, 0.53 - 0.57 and 0.71 (Table 3). The absolute identities of these components have not been established as standards were not available ior comparison. Based on spectral characteristics and relative mobilities in thin layer chromatography the components of shrimp extract would appear to be astacene, astaxanthin and astaxanthin ester. The carotenoid fraction from the digested homogenate (Figure 1), prepared with or without trypsin, separated into three zones as did the acetone extract from raw or cooked shrimp extract; however, the zone corresponding to spot 3 had a faster Rf value than did spot 3 from the starting material. Further study will be necessary to determine whether the change in Rf is the result of change(s) in the chemical structure of astaxanthin ester or to a change in association of the pigment with other components in the extract. However, the relative amounts of the minor component, tentatively identified as a degradation product of astaxanthin called astacene, did not appear to change as a result of the procedures employed for carotenoprotein isolation.
3~3~3~
rABLI~ 3: Thlrl layer chrornatoeraphy of carotenoid extracts Sarnp]e Spot' Wavelength of Relative Rf Tentative max.absorbance Amount(~)2 values identiflcation - - _~ _ _ _ ___ _ _____ _ _ Raw of cool<ed 1 475 nm 5--10 0.31-0.32 astacene shrinnp waste 2 475 nm 45-50 0.53-0.57 astaxanthin 3 475 nm 45-50 0.71 -0.72 astaxanthln ester Shrimp 1 475 nm 5-lo 0.29-0.32 astacene carotenoprotein 2 4'75 nm45-50 0.54-0.58 astaxanthin 3 475 nm 45-50 0.86-0.88 astaxanthin ester Data represent ranges obtained for 6 deterrninations; 1 = In all cases, 3 distinct components were separated from the extract; 2 Relative 20 amount estimated visually.
.. . .. ... - _ ..... .. ._ ._ . . . ,~c . . ~. . _ . . _ .. _ _ .. __ _ = _, _ , _, ,._ _ ___ 9 ~3~3~3S~
~xampLe 2 - L~xl;raction of caroteno~rotein wlth proteolytic enzyme3 A modified t`orm of` t~le procedure clescribed in FiKure 1, wa~s used to extract carotenoprotein ~rom stearned shritnp offal. The Modiflcation involved treating 25 e of the sl1rimp offal in 75 ml of 5mM phosphate b~lffer (p~l 7.7) with 25 mg of proteolytic en~yme at 50C In the absence of a chelating agent.
Using t~le modified process, the trypsins were again more effective in extracting both carotenold pigments and protein f`rom the shrimp offal than the bacterial proteases applied. The PT was most effective in extracting protein (13.71 mg/0.1 g sampla, equivalent at 90.35% of total protein in the offal) up to 30 min incubation at 50C.
After 30 min. the amount of protein extracted declined and this was probably due to excessive proteolysis giving rise to smal]er peptides and/or amino acLds that were not recovered by the ammonium sulfate treatment.
The trypsins were equally effective in extractlng total astaxanthin from shrimp offal by the modified process. The maximum amount of astaxanthin was extracted after 30 min incubation at 50C.
Beyond the 30 min lncubation period, the level of astaxanthin declined similar to the results for the protein extraction.
~ 3Owever, while the amount of protein extracted by this procedure was higher than that obtained with chelating agent at relatively lower temperatures, the maximum amount of astaxanthin extracted tabout 72.89 ug/g sample, equivalent to about 73% recovery) was lower than what was obtained when extraction was done in the presence of a chelating agent at relatively lower temperatures.
The modified process reduces substantially the extraction time and recovers more protein from the offal. However, the material so obtained may be relatively more susceptible to microbial spoilage because of the absence of E~TA. It was also observed during the extraction that the fat (carotenoid pigments) tended to separate from the protein during centrifugation. However, the two components were readily re-associated in a suspension with 5mM phosphate buffer that could be dried completely to fine powder by lyophilization.
~3~3~,3~
~o l~BIE 4: Tlme course for extraction of plgments and proteln Enzyme Time Astaxanthin Protein n applied (mln) ~g/g sample % recovery
----- ... - .. ... _. ..
~5~ 13~38'~
Amino acid cornpo~,itlon of carotenoproteln The amino aci(l data presented in Table 2 indleate that carotenoprotein isolate(l by t~le procedure outllned in Fi8ure l, is particularly rlcn in elutamic acid and aspartlc acid, similar to earlier findings on carotenoprotein derived from a copepod. The amino aeid composition of the produet extracted with bovine trypsin is only marginally different from that of the untreated product. On a rnole percent basis, the carotenoprotein obtained by extraction with bovine trypsin is a somewhat better source of essential amino acids isoleucine, leucine, phenylalanine, threonine, tryptophan and tyrosine than the earotenoprotein obtained ln the absenee of added enzymes; whieh in turn is a somewhat better source of arglnine, methionine and lysine. The valine and histidine levels of the carotenoprotein extraeted wlth bovine trypsin were slmilar to those in the product obtained in the absence of added en~yme. Figure 2 compares the levels of essential amino acids from rainbow trout nutrition with the carotenoprotein isolate prepared with bovLne trypsin. The carotenoprotein isolate contains an exeess of essential amino aeids required for rainbow trout. As ean be seen from Figure 2 a ration eontaining 40~ earotenoprotein, and no other protein source, would be more than adequate in all essential arnino aeids with exception of cystine. The second limiting amino acids are methionine, arginine and lysine. A ration of l~o~ carotenoprotein would also eontain more that 50 me% of earotenoids, an amount suffieient to pigment rainbow trout.
-6- 13~3~
. I'ABL.E 2: Amino Acid Levels in Carotenoprotein Amino AcidControlcontrolBT-treatedBT-treated ,~ proteinmole ,~6% proteinmole ',~
Alanine 5.17 7.97 5.20 7.75 Arginine 6.12 4.83 4.46 3.39 Aspartate11.14 11,,49 10.80 10.77 Cysteic acid 0.22 0.17 0.77 0.60 Cystine O.IJ0 0,46 0.58 0.65 Clutamate12.06 11,,26 11.78 l0.63 Glycine 4.46 8,18 ll.77 8.43 Histidine3.02 2.67 2.95 2.52 Hydroxylysine o.o9 o.o7 0.22 0,17 Hydroxyproline 0.09 0.07 0.18 0.20 Isoleucine4.68 4.89 5-14 5.18 Leucine 7.05 7.37 7.97 8.06 Lysine 6.71 6.28 5.66 5.14 Methionine2.62 2.40 1.88 1.68 Phenylalanine 1l.83 4.01 5.66 4,54 Proline 4.25 5.07 4.3ll 5.00 Serine 4.68 6.09 5.54 6.97 Taurine 0.09 0.12 0.12 0.14 Threonine5.38 6.21 6.25 6.95 Tryptophan1.17 0.78 2.40 1.56 Tyrosine 4.3ll 3.29 4.86 3.56 Valine 5.42 6.33 5.42 6.11 . . . ~
Data are averaee values of duplicate determinations.
~7 131383~
Recovery of c~IrotenoLcI plgments Approxl~nately ~0% of the carotenoids with shrimp processing wastes (Il - 12 mg% fwb) were recovered in the carotenoproteLn fractlon when bovine trypsin was included in the extraction medium. The use of trypsin increased the recovery of pigment at all extractlon tlmes employed. The bacterial protease was le~s effective than trypsin(s) in recovering carotenoprotein despite its effectiveness in solubilizing protein. The specificity of this enzyme is broader than that of trypsin and its action may result in excessive hydrolysis of protein associated with the carotenoprotein complex and thereby lead to insolubllity ln the aqueous extraction solution or to instability due to dlsruptlon of the protective environment provided by association with protein. Further study with different enzymes, as well as varying concentrations of en~ymes will be necessary to elucidate the reason for the dLfferences in yield obtained wlth trypsin and bacterial protease.
The maximum absorbance of the carotenoid fraction from shrimp waste and from carotenoprotein isolate was ~I75 nm in petroleum ether.
These results are consistent with other reports for total astaxanthin.
Thin layer chromatography of the carotenoLd fraction from raw or cooked shrimp offal separated three distinct orange-red components. The separated components of raw and cooked shrimp waste had Rf's 0.29 -0.32, 0.53 - 0.57 and 0.71 (Table 3). The absolute identities of these components have not been established as standards were not available ior comparison. Based on spectral characteristics and relative mobilities in thin layer chromatography the components of shrimp extract would appear to be astacene, astaxanthin and astaxanthin ester. The carotenoid fraction from the digested homogenate (Figure 1), prepared with or without trypsin, separated into three zones as did the acetone extract from raw or cooked shrimp extract; however, the zone corresponding to spot 3 had a faster Rf value than did spot 3 from the starting material. Further study will be necessary to determine whether the change in Rf is the result of change(s) in the chemical structure of astaxanthin ester or to a change in association of the pigment with other components in the extract. However, the relative amounts of the minor component, tentatively identified as a degradation product of astaxanthin called astacene, did not appear to change as a result of the procedures employed for carotenoprotein isolation.
3~3~3~
rABLI~ 3: Thlrl layer chrornatoeraphy of carotenoid extracts Sarnp]e Spot' Wavelength of Relative Rf Tentative max.absorbance Amount(~)2 values identiflcation - - _~ _ _ _ ___ _ _____ _ _ Raw of cool<ed 1 475 nm 5--10 0.31-0.32 astacene shrinnp waste 2 475 nm 45-50 0.53-0.57 astaxanthin 3 475 nm 45-50 0.71 -0.72 astaxanthln ester Shrimp 1 475 nm 5-lo 0.29-0.32 astacene carotenoprotein 2 4'75 nm45-50 0.54-0.58 astaxanthin 3 475 nm 45-50 0.86-0.88 astaxanthin ester Data represent ranges obtained for 6 deterrninations; 1 = In all cases, 3 distinct components were separated from the extract; 2 Relative 20 amount estimated visually.
.. . .. ... - _ ..... .. ._ ._ . . . ,~c . . ~. . _ . . _ .. _ _ .. __ _ = _, _ , _, ,._ _ ___ 9 ~3~3~3S~
~xampLe 2 - L~xl;raction of caroteno~rotein wlth proteolytic enzyme3 A modified t`orm of` t~le procedure clescribed in FiKure 1, wa~s used to extract carotenoprotein ~rom stearned shritnp offal. The Modiflcation involved treating 25 e of the sl1rimp offal in 75 ml of 5mM phosphate b~lffer (p~l 7.7) with 25 mg of proteolytic en~yme at 50C In the absence of a chelating agent.
Using t~le modified process, the trypsins were again more effective in extracting both carotenold pigments and protein f`rom the shrimp offal than the bacterial proteases applied. The PT was most effective in extracting protein (13.71 mg/0.1 g sampla, equivalent at 90.35% of total protein in the offal) up to 30 min incubation at 50C.
After 30 min. the amount of protein extracted declined and this was probably due to excessive proteolysis giving rise to smal]er peptides and/or amino acLds that were not recovered by the ammonium sulfate treatment.
The trypsins were equally effective in extractlng total astaxanthin from shrimp offal by the modified process. The maximum amount of astaxanthin was extracted after 30 min incubation at 50C.
Beyond the 30 min lncubation period, the level of astaxanthin declined similar to the results for the protein extraction.
~ 3Owever, while the amount of protein extracted by this procedure was higher than that obtained with chelating agent at relatively lower temperatures, the maximum amount of astaxanthin extracted tabout 72.89 ug/g sample, equivalent to about 73% recovery) was lower than what was obtained when extraction was done in the presence of a chelating agent at relatively lower temperatures.
The modified process reduces substantially the extraction time and recovers more protein from the offal. However, the material so obtained may be relatively more susceptible to microbial spoilage because of the absence of E~TA. It was also observed during the extraction that the fat (carotenoid pigments) tended to separate from the protein during centrifugation. However, the two components were readily re-associated in a suspension with 5mM phosphate buffer that could be dried completely to fine powder by lyophilization.
~3~3~,3~
~o l~BIE 4: Tlme course for extraction of plgments and proteln Enzyme Time Astaxanthin Protein n applied (mln) ~g/g sample % recovery
5 -- ~
BT 10 48.96 50.75 7 PT 49.95 57.15 2 EP 42.99 42.90 2 BP 42.12 49.26 2 BT 20 65.00 76.73 7 PT 60.77 82.96 2 EP 53.88 66.65 2 BP 52.55 70.15 2 BT 30 72.89 85.90 7 PT 70.37 90.35 2 EP 61.45 70.15 2 BP 60.71 74.15 2 BT 40 59.07 78.07 7 PT 56.38 78.70 2 EP 1~6.03 57.25 2 BP 48.99 66.10 2 - _ Total protein in shrimp offal was determined as 15.17 mg/100mg sample by the 8iuret method; total astaxanthin was determined as 105.2~g/g sample by the method oi` Saito and Regier 1971; n = number of times determinations were carried out.
BP = Biocon [TM] bacterial protease.
It should be emphasized that the process with a chelating agent is best carried out at low temperatures to minimize undesirable reactions during the slower action of the chelating agent. When the chelating agent is not used the process is best done at high temperature (e.g.
50C) using more enzyme.
3 ~
StabiLity o~ Caroterlolds wlth Carotenoprotein Incubatlon of` the fiLtrate fraction obtained by bovine trypsln treatment (flgure 1), for 21 days at llC or at 30C resulted in about 60%
109s of total carotenolds. The filtrate fraction did not develop off odor or show usual signs of bacterial spoilage for the duration of the experiment. This would appear to be due to the preservatlve value of trisodium ED'I'A.
Inclusion of antioxidant (BHT) and protease inhibitor (trasylol) with the flltrate fraction was very effective in stabilizlng the carotenoids at 30C aud less effective at 40C. The 8reater stability of shrimp carotenoids at higher temperature indicates carotenoicls may be lost by a coupled oxidatlon mechanlsm. It is known that the oxidation of carotenoid pigments may be coupled to the oxidation of poLyunsaturated fatty acids and the enzymic oxidation of certain fLsh lipids may occur more rapidly at temperatures near 0C than at temperatures near 30C. It would seem from the foregoing that the initial heat treatment was not adequate to effectively inactivate enzymes that participate in the oxidation process, and further treatment of shrimp waste to completely inactivate suoh enzymes may improve the stability of the produot at 40C.
The finding that trasylol in combination with or without BHT aids in stabilizing the carotenoid fraction may be explained on the basis that continued protein hydrolysis decreases the protective value related to protein-pigment association Extraction of carotenoprotein from crustacean offal improves the nutritive value of the raw material by reducing the content of ash and chitin and ef`fectively concentrating protein. The process recovers the carotenoid fraction in an aqueous dispersion. The recovery of carotenoids is desirable since its addition to the rations of pen reared salmonids serves to color the flesh and give a product having a desirable orange-red color. The presence of residual EDTA with the product appears to prevent microbial deterioration. The loss of carotenoids in the carotenoprotein extract can be prevented by addition of protease inhibitor and antioxidant and holding at 30C.
BT 10 48.96 50.75 7 PT 49.95 57.15 2 EP 42.99 42.90 2 BP 42.12 49.26 2 BT 20 65.00 76.73 7 PT 60.77 82.96 2 EP 53.88 66.65 2 BP 52.55 70.15 2 BT 30 72.89 85.90 7 PT 70.37 90.35 2 EP 61.45 70.15 2 BP 60.71 74.15 2 BT 40 59.07 78.07 7 PT 56.38 78.70 2 EP 1~6.03 57.25 2 BP 48.99 66.10 2 - _ Total protein in shrimp offal was determined as 15.17 mg/100mg sample by the 8iuret method; total astaxanthin was determined as 105.2~g/g sample by the method oi` Saito and Regier 1971; n = number of times determinations were carried out.
BP = Biocon [TM] bacterial protease.
It should be emphasized that the process with a chelating agent is best carried out at low temperatures to minimize undesirable reactions during the slower action of the chelating agent. When the chelating agent is not used the process is best done at high temperature (e.g.
50C) using more enzyme.
3 ~
StabiLity o~ Caroterlolds wlth Carotenoprotein Incubatlon of` the fiLtrate fraction obtained by bovine trypsln treatment (flgure 1), for 21 days at llC or at 30C resulted in about 60%
109s of total carotenolds. The filtrate fraction did not develop off odor or show usual signs of bacterial spoilage for the duration of the experiment. This would appear to be due to the preservatlve value of trisodium ED'I'A.
Inclusion of antioxidant (BHT) and protease inhibitor (trasylol) with the flltrate fraction was very effective in stabilizlng the carotenoids at 30C aud less effective at 40C. The 8reater stability of shrimp carotenoids at higher temperature indicates carotenoicls may be lost by a coupled oxidatlon mechanlsm. It is known that the oxidation of carotenoid pigments may be coupled to the oxidation of poLyunsaturated fatty acids and the enzymic oxidation of certain fLsh lipids may occur more rapidly at temperatures near 0C than at temperatures near 30C. It would seem from the foregoing that the initial heat treatment was not adequate to effectively inactivate enzymes that participate in the oxidation process, and further treatment of shrimp waste to completely inactivate suoh enzymes may improve the stability of the produot at 40C.
The finding that trasylol in combination with or without BHT aids in stabilizing the carotenoid fraction may be explained on the basis that continued protein hydrolysis decreases the protective value related to protein-pigment association Extraction of carotenoprotein from crustacean offal improves the nutritive value of the raw material by reducing the content of ash and chitin and ef`fectively concentrating protein. The process recovers the carotenoid fraction in an aqueous dispersion. The recovery of carotenoids is desirable since its addition to the rations of pen reared salmonids serves to color the flesh and give a product having a desirable orange-red color. The presence of residual EDTA with the product appears to prevent microbial deterioration. The loss of carotenoids in the carotenoprotein extract can be prevented by addition of protease inhibitor and antioxidant and holding at 30C.
Claims (12)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the extraction of carotenoproteins from crustacean waste comprising the steps of:
(a) homogenizing said crustacean waste in water to form a homogenizate;
(b) treating said homogenizate with at least 0.1% w/w based on said crustacean waste of a proteolyte enzyme selected from the groups consisting of animal derived trypsin and a bacterial protease, at a temperature of 0°C to 50°C for from 1 to 24 hours; and (c) separating an aqueous solution of carotenoproteins therefrom, said carotenoproteins being substantially free of chitin and ash.
(a) homogenizing said crustacean waste in water to form a homogenizate;
(b) treating said homogenizate with at least 0.1% w/w based on said crustacean waste of a proteolyte enzyme selected from the groups consisting of animal derived trypsin and a bacterial protease, at a temperature of 0°C to 50°C for from 1 to 24 hours; and (c) separating an aqueous solution of carotenoproteins therefrom, said carotenoproteins being substantially free of chitin and ash.
2. The process of claim 1 wherein said homogenization steps is carried out in the presence of a chelating agent.
3. The process of claim 2 wherein said chelating agent is ethylene diamine tetraacetic acid.
4. The process of claim 1 wherein said trypsin is bovine pancreas trypsin or porcine pancreas trypsin.
5. The process of claim 1 wherein said bacterial protease is ENZECO AP-1TM or BIOCONTM.
6. The process of claim 1 wherein said treating step is carried out in the presence of a phosphate buffer.
7. The process of claim 1 including the step of adding an antioxidant and a protease inhibitor to said treated homogenizate before said separation step.
8. The process of claim 7 wherein said antioxidant is BHT
and wherein said protease inhibitor is trasylol.
and wherein said protease inhibitor is trasylol.
9. An extract composition comprising a carotenoprotein substantially free of chitin and ash and containing major amounts of free astaxanthin, astaxanthin ester and purer amounts of astacene.
10. The extract composition of claim 9 in combination with a protease inhibitor and an antioxidant.
11. The extract composition of claim 10 wherein said protease inhibitor is trasylol and wherein said antioxidant is BHT.
12. A feed supplement containing the extract composition of claims 9, 10 or 11.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA000487392A CA1313835C (en) | 1985-07-24 | 1985-07-24 | Extraction of carotenoproteins from crustacean wastes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA000487392A CA1313835C (en) | 1985-07-24 | 1985-07-24 | Extraction of carotenoproteins from crustacean wastes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1313835C true CA1313835C (en) | 1993-02-23 |
Family
ID=4131040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000487392A Expired - Fee Related CA1313835C (en) | 1985-07-24 | 1985-07-24 | Extraction of carotenoproteins from crustacean wastes |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1313835C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6056981A (en) * | 1994-02-28 | 2000-05-02 | Biozyme Systems Inc. | Euphausiid harvesting and processing method and apparatus |
WO2001077230A2 (en) * | 2000-04-05 | 2001-10-18 | Hafsteinn Helgason | Recovery of compounds using a natural adsorbent |
ES2970416A1 (en) * | 2022-10-25 | 2024-05-28 | Consejo Superior Investigacion | CRUSTACIANIN EXTRACTION PROCEDURE (Machine-translation by Google Translate, not legally binding) |
-
1985
- 1985-07-24 CA CA000487392A patent/CA1313835C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6056981A (en) * | 1994-02-28 | 2000-05-02 | Biozyme Systems Inc. | Euphausiid harvesting and processing method and apparatus |
WO2001077230A2 (en) * | 2000-04-05 | 2001-10-18 | Hafsteinn Helgason | Recovery of compounds using a natural adsorbent |
WO2001077230A3 (en) * | 2000-04-05 | 2002-06-27 | Hafsteinn Helgason | Recovery of compounds using a natural adsorbent |
US7052721B2 (en) | 2000-04-05 | 2006-05-30 | Hafsteinn Helgason | Recovery of compounds using a natural adsorbent |
ES2970416A1 (en) * | 2022-10-25 | 2024-05-28 | Consejo Superior Investigacion | CRUSTACIANIN EXTRACTION PROCEDURE (Machine-translation by Google Translate, not legally binding) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Villamil et al. | Fish viscera protein hydrolysates: Production, potential applications and functional and bioactive properties | |
Chalamaiah et al. | Fish protein hydrolysates: Proximate composition, amino acid composition, antioxidant activities and applications: A review | |
EP1123368B1 (en) | Method of extracting lipids from marine and aquatic animal tissues | |
Kristinsson | Aquatic food protein hydrolysates | |
Mizani et al. | An effective method for producing a nutritive protein extract powder from shrimp-head waste | |
Sila et al. | Isolation and characterisation of carotenoproteins from deep-water pink shrimp processing waste | |
Shahidi | Proteins from seafood processing discards | |
Guérard | Enzymatic methods for marine by-products recovery | |
Ezquerra‐Brauer et al. | Recent trends for the employment of jumbo squid (Dosidicus gigas) by‐products as a source of bioactive compounds with nutritional, functional and preservative applications: a review | |
Nemati et al. | A study on the properties of alosa (Alosa caspia) by-products protein hydrolysates using commercial enzymes | |
Sinthusamran et al. | Protein hydrolysates from Pacific white shrimp cephalothorax manufactured with different processes: compositions, characteristics and antioxidative activity | |
Mohanty et al. | Future prospects and trends for effective utilization of fish processing wastes in India | |
US5151500A (en) | Process for producing a substantially heme-free blood protein | |
Haard et al. | Biotechnological applications of seafood proteins and other nitrogenous compounds | |
CA1313835C (en) | Extraction of carotenoproteins from crustacean wastes | |
Abd El‐Rady et al. | Effect of different hydrolysis methods on composition and functional properties of fish protein hydrolysate obtained from bigeye tuna waste | |
Phadke et al. | Angiotensin-I converting enzyme (ACE) inhibitory activity and antioxidant activity of fermented fish product ngari as influenced by fermentation period | |
JPH1156346A (en) | Hematococcus algal body containing astaxanthin and its extract | |
Ya et al. | Carotenoproteins from lobster waste as a potential feed supplement for cultured salmonids | |
Simpson et al. | Recovery and characteristics of carotenoprotein from lobster (Homarus americanus) waste | |
KR102085775B1 (en) | Method for separating and purifying DHA from tuna bark | |
RU2676312C1 (en) | Method of obtaining protein-vitamin supplement from caviar juice | |
Kristinsson | 23 The Production, Properties, and Utilization of Fish Protein Hydrolysates | |
Abdulazeez et al. | Production and antioxidant properties of protein hydrolysate from Rastrelliger kanagurta (Indian mackerel). | |
JPH11206335A (en) | Antiallergic natural seasoning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |